NCT04661683

Brief Summary

In the United States, secondhand smoke is the third leading preventable cause of death. Flavored hookah (waterpipe) tobacco smoking, a highly social activity common in hookah bars, is a key source of SHS exposure. While smoke-free air laws have decreased exposure to secondhand smoke, the majority of laws do not include hookah smoking. Thus, as a social outlet for youth and young adults, hookah smoke exposure may harm non-smokers, including women of reproductive age or pregnant, hookah bar workers, children, and individuals with heart and lung disease. While more is known on the acute effects of active hookah smoking and the literature is emerging on active e-hookah vaping, little is known about the acute vascular effects of secondhand exposure to hookah smoke and aerosol. The study aims to examine the acute effects of secondhand exposure of hookah smoke and aerosol on endothelial and vascular function. Eligible volunteers will be invited to participate in a total of 3 study visits (2-3 hours each): e-hookah aerosol exposure, charcoal-heated hookah smoke exposure and smoke-free room air. Non-invasive blood pressure and blood flow measurements will be taken before and after the exposure sessions.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
12mo left

Started Jun 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Jun 2021Apr 2027

First Submitted

Initial submission to the registry

December 3, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 10, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

June 25, 2021

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2027

Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

5.5 years

First QC Date

December 3, 2020

Last Update Submit

April 17, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Flow-Mediated Dilation (FMD)

    Using ultrasound, FMD of the brachial artery induced by reactive hyperemia, will be used to measure endothelium-dependent vasodilator function. Baseline diameter and velocity will be recorded for 45 seconds and resumed 30 seconds before cuff deflation and continuously for 2 minutes after deflation to obtain true peak vasodilatory response.

    Pre- and post- the 60-minute exposure sessions

  • Arterial stiffness

    Using applanation tonometry, pulse wave velocity will be used to measure cebtral arterial stiffness.

    Pre- and post- the 60-minute exposure sessions

Study Arms (3)

Exposure to Combustible Hookah Smoke

EXPERIMENTAL

Participants will be exposed to combustible hookah smoke. To mitigate the impact of carryover effects, the exposure sessions will be separated by a minimum of 7-days.

Other: Combustible Hookah Smoke

Exposure to Electronic Hookah Aerosol

EXPERIMENTAL

Participants will be exposed to electronic hookah aerosol. To mitigate the impact of carryover effects, the exposure sessions will be separated by a minimum of 7-days.

Other: Electronic Hookah Aerosol

Exposure to Clean Air

EXPERIMENTAL

Participants will be exposed to Clean Room Air. To mitigate the impact of carryover effects, the exposure sessions will be separated by a minimum of 7-days.

Other: Clean Room Air

Interventions

Exposure to combustible hookah smoke for a duration of 60 minutes.

Exposure to Combustible Hookah Smoke

Exposure to electronic hookah aerosol for a duration of 60 minutes.

Exposure to Electronic Hookah Aerosol

Exposure to room air for a duration of 60 minutes.

Exposure to Clean Air

Eligibility Criteria

Age21 Years - 49 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years old
  • Never a smoker: do not use any tobacco products or nicotine delivery systems, including cigarettes, cigars (traditional and filtered), cigarillos, hookah, smokeless tobacco (i.e., loose snus, moist snuff, dip, spit, or chewing tobacco), pipe tobacco, snus pouches, dissolvable tobacco or vaping.
  • no evidence of cardiopulmonary disease by history/physical
  • blood pressure (BP) \< 140/90 mmHg
  • resting heart rate (HR) \< 100 bpm
  • BMI \>18 or \< 30kg•m2
  • no prescription medication
  • No exposure to environmental tobacco smoke for at least one week prior to the study date.

You may not qualify if:

  • exhaled carbon monoxide \>6 ppm
  • (+) pregnancy test
  • other conditions deemed unsafe to participate, such as breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Los Angeles

Los Angeles, California, 90095-8361, United States

Location

MeSH Terms

Conditions

Water Pipe SmokingVaping

Condition Hierarchy (Ancestors)

Pipe SmokingSmokingBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 3, 2020

First Posted

December 10, 2020

Study Start

June 25, 2021

Primary Completion (Estimated)

December 15, 2026

Study Completion (Estimated)

April 15, 2027

Last Updated

April 22, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations